Michael Petusky
Stock Analyst at Barrington
(3.77)
# 2,046
Out of 5,118 analysts
626
Total ratings
44.9%
Success rate
3.6%
Average return
Main Sectors:
Stocks Rated by Michael Petusky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HAE Haemonetics | Reiterated: Buy | $140 → $145 | $119.93 | +20.90% | 71 | Nov 6, 2026 | |
| USPH U.S. Physical Therapy | Reiterated: Buy | $98 → $110 | $99.49 | +10.56% | 62 | Nov 6, 2026 | |
| LMAT LeMaitre Vascular | Reiterated: Buy | $95 → $91 | $80.89 | +12.50% | 60 | Nov 5, 2026 | |
| HSIC Henry Schein | Reiterated: Buy | $104 | $86.05 | +20.86% | 50 | Nov 4, 2026 | |
| LFCR Lifecore Biomedical | Reiterated: Hold | n/a | $6.36 | - | 42 | Nov 4, 2026 | |
| OPCH Option Care Health | Reiterated: Hold | n/a | $31.65 | - | 60 | Nov 4, 2026 | |
| BVS Bioventus | Reiterated: Buy | $18 → $16 | $10.61 | +50.80% | 9 | Nov 3, 2026 | |
| MMSI Merit Medical Systems | Reiterated: Buy | $114 → $116 | $87.23 | +32.98% | 85 | Oct 30, 2026 | |
| VMD Viemed Healthcare | Reiterated: Buy | $14 | $9.13 | +53.34% | 3 | Oct 27, 2026 | |
| XRAY DENTSPLY SIRONA | Reiterated: Buy | $15 → $13 | $9.46 | +37.42% | 58 | Oct 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $14.55 | +58.08% | 52 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $2.25 | $1.73 | +30.06% | 55 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $14 | $7.87 | +77.89% | 13 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.5 | $0.624 | +140.38% | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $35.41 | n/a | 1 | Jun 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 2 | Dec 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $30 | $20.05 | n/a | 1 | Apr 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6.5 | $1.00 | n/a | 1 | Aug 14, 2013 |
Haemonetics
Nov 6, 2026
Reiterated: Buy
Price Target: $140 → $145
Current: $119.93
Upside: +20.90%
U.S. Physical Therapy
Nov 6, 2026
Reiterated: Buy
Price Target: $98 → $110
Current: $99.49
Upside: +10.56%
LeMaitre Vascular
Nov 5, 2026
Reiterated: Buy
Price Target: $95 → $91
Current: $80.89
Upside: +12.50%
Henry Schein
Nov 4, 2026
Reiterated: Buy
Price Target: $104
Current: $86.05
Upside: +20.86%
Lifecore Biomedical
Nov 4, 2026
Reiterated: Hold
Price Target: n/a
Current: $6.36
Upside: -
Option Care Health
Nov 4, 2026
Reiterated: Hold
Price Target: n/a
Current: $31.65
Upside: -
Bioventus
Nov 3, 2026
Reiterated: Buy
Price Target: $18 → $16
Current: $10.61
Upside: +50.80%
Merit Medical Systems
Oct 30, 2026
Reiterated: Buy
Price Target: $114 → $116
Current: $87.23
Upside: +32.98%
Viemed Healthcare
Oct 27, 2026
Reiterated: Buy
Price Target: $14
Current: $9.13
Upside: +53.34%
DENTSPLY SIRONA
Oct 26, 2026
Reiterated: Buy
Price Target: $15 → $13
Current: $9.46
Upside: +37.42%
Oct 22, 2026
Reiterated: Buy
Price Target: $23
Current: $14.55
Upside: +58.08%
Oct 16, 2026
Upgraded: Buy
Price Target: $2.25
Current: $1.73
Upside: +30.06%
Aug 6, 2026
Reiterated: Buy
Price Target: $17 → $14
Current: $7.87
Upside: +77.89%
Jan 6, 2026
Reiterated: Buy
Price Target: $1.5
Current: $0.624
Upside: +140.38%
Jun 9, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $35.41
Upside: n/a
Dec 18, 2017
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Apr 25, 2016
Upgraded: Buy
Price Target: $30
Current: $20.05
Upside: n/a
Aug 14, 2013
Rated: Buy
Price Target: $6.5
Current: $1.00
Upside: n/a